Summary of Trading Off The Bottom - February 16.
At
Summary of Trading Off The Bottom - February 16.
At .0002:
December 8: 3M
December 11: 6M
December 12: 3M
December 13: 10M
December 14: 52M
December 15: 14M
December 18: 19M
December 19: 14M
December 20: 22M
December 21: 18M
December 22: 7M
December 26: 34M
December 27: 24M
December 28: 24M
December 29: 43M
January 2: 17M
January 3: 13M
January 4: 9M
January 5: 3M
January 8: 12M
January 9: 10M
January 10: 20M
January 11: 28M
January 12: 10M
January 16: 30M
January 17: 4M
January 18: 8M
January 19: 13M
January 22: 8M
January 23: 5M
January 24: 3M
January 25: 21M
January 26: 5M
January 29: 2M
January 30: 3M
January 31: 6M
February 1: 4M
February 2: 11M
February 5: 2M
February 6: 2M
February 7: 5M
February 8: 2M
February 9: 4M
February 12: 2M
February 13: 2M
February 14: 4M
February 15: 2M
February 16: 1M [rounded down]
Total: 564M
At .0001:
December 7: 415M [260M bought on bid / 155M bought on ask].
December 8: 366M
December 11: 8M
December 12: 219M
December 13: 22M
December 14: 25M
December 15: 1M
December 19: 3M
December 20: 19M
December 21: 6M
December 22: 3M
December 23: 2M
December 28: 10M
December 29: 5M
January 2: 2M
January 3: 12M
January 4: 9M
January 5: 2M
January 8: 20M
January 10: 7M
January 11: 5M
January 12: 2M
January 16: 8M
January 18: 2M
January 19: 15M
January 23: 1M
January 24: 2M
January 25: 3M
January 29: 1M
January 30: 1M
January 31: 9M
February 1: 6M
February 5: 2M
February 7: 1M
February 8: 1M
February 12: 5M [rounded up]
February 13: 5M [rounded down]
February 14: 3M
February 15: 1M
Total 1.000 B
In addition the following quantities of .0001s may be in the hands of retail investors if not sold even on December 7:
November 29: 4M
December 5: 170M
December 6: 113M
Total: 287M
Discounting late print of 90M + 82,540,103 at .00098 Form T on December 12 which did not got to retail.
Discounting late print of 4 x 90M + 80.699.580M at .000098 Form T on December 7 which did not go to retail.
Discounting assumed mirror trades of 4 x 90M + 20,000,200 at .000098 then at .0001 on December 5. Might need to assume later that 380M or 760M acquired at .0001 - will become evident when .0002s and .0003s bought out.
Discounting assumed mirror trades of 2 x 90M + 56,499,900 at .0001 then .000098 on November 29. Might need to assume later that 236M or 472M acquired at .0001 - will become evident when .0002s and .0003s bought out.
Tersis Technologies, Inc. (TERS) Stock Research Links
"Per Ardua Ad Astra" - "Through Adversity To The Stars"
A very apposite motto for those who trade successfully in the OTC market..
All posts are my opinion - trade at your own risk.
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Payout Boost for Income-Hungry Investors You know, it ain't every day you hear about dividend increases across the board. But Infrastructure Capital Advisors, that investment management powerhouse, is dishing out more dough to its investors through a dividend uptick. They're bumping up the payouts on not just one, but four of their ETFs: Bond Income ETF (BNDS), Equity...
Continue Reading
Who's Pointing Fingers at Papa John's? Papa John's International, Inc. (NASDAQ: PZZA) is now headlining a courtroom drama that sounds as crispy as their pizza crust. Last ditch deadline's pinned for November 2, 2026, for grabbing the top spot as lead plaintiff against Papa John’s top brass, Todd Allan Penegor and former CFO Ravi Thanawala. These head honchos reportedly...
Continue Reading
From Sticker Dreams to Racing Reality Some days bring surprises outside the typical ticker watch as those market charts get shoved aside, right when fans' stories race onto the scene. What McLaren and Velo cooked up for the Mexico City Grand Prix has got me pausing—a blend of motorsport passion and grassroots creativity. By unveiling the 'Livery of Dreams,' McLaren puts...
Continue Reading
An Industry Insider Speaks on Global Stage In the shuffle of corporate presentations and industry meet-ups, let's put Ramaco Resources and their executive vice president, Mike Woloschuk, into sharper focus. In Paris, he's set to address the plenary session of the International Energy Agency's Coal Industry Advisory Board. His talk titled 'Bringing Critical Minerals...
Continue Reading
Propane Power Play in Florida's Market Here's a little tune you don't hear every day: two local businesses tangoing to the beat of expansion without making a public peep about the price. Palmdale Propane, a powerhouse under the Palmdale Oil umbrella, just snapped up Affordable Gas, a local player from Belle Glade, Florida. This acquisition strengthens its grip on the...
Continue Reading
A New Era for Young Learners in Bellevue When a community-driven school like BASIS Independent Bellevue makes a move to expand, it doesn't happen in a vacuum. They're not just building another campus—they're aiming to sculpt the future right here in Bellevue, and boy, do they have a plan. The new Lower School campus opening come Fall 2027 is dedicated to kiddos in...
Continue Reading
There's a fresh breeze blowing through the dusty corridors of healthcare, shaking things up for the better. You see, Genefluence, the brainchild of Professor Chris Toumazou, isn't just throwing a bunch of tech jargon around—it's setting the stage for a much-needed shake-up in how we handle urinary tract infections (UTIs) and, believe me, it couldn’t have come sooner....
Continue Reading
The Unexpected Slide of Beta Bionics So your wallet took a bruising with this Beta Bionics deal, eh? It’s another one of those wild tales from the stock jungle where everyone watching the NASDAQ:BBNX action got clipped when reality didn't match the company chest-thumping. Glancy Prongay Wolke & Rotter LLP just laid it out—ripping the Band-Aid off what Beta Bionics...
Continue Reading
High-Risk Lending Meets Military Protections Ever seen a seemingly legal scheme that just leaves a sour taste? That's the vibe with CashNetUSA right now. They've landed in the hot seat over allegedly sky-high interest rates served up to folks who put on a uniform. We're talking about a proposed nationwide class action lawsuit accusing the lender of giving active-duty...
Continue Reading
Setting New Records in the AV Industry There's buzz in the air over in Hoboken, New Jersey. Xyte, the AI cloud maestro you're starting to hear about more and more, has just smashed its own records this past September. It's not just a flash in the pan, either—this isn't the first time they've knocked it out of the park. Thanks to burgeoning enterprise demand and a...
Continue Reading
Top 5 Most Recently Viewed Articles
Boosty Labs Moves Forward with Strategic Leadership Changes Boosty Labs, a prominent name in Blockchain, Bitcoin, and Web3 development, is taking a substantial leap forward. As the company prepares for significant growth, the leadership team has undergone key changes aimed at driving operational excellence and innovation. New Roles for Vitalii Yatskiv and Denys Doronin In...
Continue Reading
Sinclair Inc. Elevates Leadership With Key Promotions BALTIMORE - Sinclair Inc. (NASDAQ: SBGI), a significant force in the media landscape recognized for its local news and sports coverage, with a market capitalization of $963 million, has recently elevated several key executives within its organizational structure and various subsidiaries. These strategic executive...
Continue Reading
Nasus Pharma Completes Initial Public Offering Nasus Pharma Ltd. (NYSE: NSRX) recently celebrated the successful conclusion of its initial public offering (IPO), marking a significant milestone for the company. This clinical-stage pharmaceutical firm, based in Israel, specializes in developing innovative intranasal products designed for treating emergency medical...
Continue Reading
Introducing the Keurig® K-Mini Mate™ Brewer The world of coffee brewing has evolved with the introduction of the Keurig® K-Mini Mate™ Brewer. This remarkable machine, available exclusively at Target, marks a significant leap in convenience and taste. Notably small at just 4 inches wide, this brewer is perfect for anyone who values space without wanting to sacrifice...
Continue Reading
Join Telix Pharmaceuticals for a Pioneering Webinar Telix Pharmaceuticals Limited (ASX: TLX, Nasdaq: TLX) is excited to extend an invitation to investors for a comprehensive webinar centered on the company’s leading-edge developments in urology. This event will highlight innovative approaches to treating prostate and kidney cancers, showcasing the remarkable potential...
Continue Reading